AstraZeneca (LSE:AZN)
AstraZeneca is a biopharmaceutical business that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three main therapy areas - Respiratory, Inflammation and Autoimmunity (RIA), Cardiovascular and Metabolic Disease (CVMD) and Oncology – as well as in Infection and Neuroscience.
{{ formattedPrice }} {{ change }} (-1.22%)
Quotes delayed. Last trade: 24-01-2019, 08:41:25am GMT
| Open Price | {{ openPrice }} | Close Price | {{ closePrice }} |
| Day High | {{ high }} | Day Low | {{ low }} |
| Bid | {{ bid }} | Ask | {{ ask }} |
| Volume | 182897 |
Related Articles
-
Will AstraZeneca continue to outperform in 2019?
Andy Ross sees plenty to be upbeat about at AstraZeneca plc (LON:AZN) that he thinks could keep it beating the FTSE 100 (INDEXFTSE: UKX)... Read More »
-
Why I’d pick the GSK and AstraZeneca share prices to beat my State Pension
I'm looking to re-invest a company pension, and here's why AstraZeneca plc (LON: AZN) and GlaxoSmithKline plc (LON: GSK) shares are on my list. Read More »
-
The AstraZeneca and GSK share prices look like buys to me as the FTSE 100 crashes
Harvey Jones says AstraZeneca plc (LON: AZN) and GlaxoSmithKline plc (LON: GSK) have the antidote to the current FTSE 100 (INDEXFTSE: UKX) gloom. Read More »
-
I think this FTSE 100 dividend stock could be poised for big gains in 2019
Royston Wild identifies a FTSE 100 (INDEXFTSE: UKX) income hero that could sprint still higher in 2019. Read More »
-
The AstraZeneca share price has smashed the FTSE 100 in 2018. I say it could do so again in 2019
Rupert Hargreaves explains why he thinks AstraZeneca plc (LON:AZN) will continue to outperform the FTSE 100 (INDEXFTSE: UKX). Read More »
-
Why I think AstraZeneca should be in your 2019 share portfolio
AstraZeneca plc (LON: AZN) has multiple positive catalysts and I see a buying opportunity right now. Read More »
-
3 FTSE 100 shares I think are better than a buy-to-let property
If you're thinking of investing in buy-to-let, these three stocks could be a better buy, says Andy Ross. Read More »
-
Could AstraZeneca boost your retirement income as the State Pension age rises?
Could AstraZeneca plc’s (LON: AZN) dividend prospects help to offset the challenges posed by the State Pension? Read More »
-
Forget 1.5% from a cash ISA. FTSE 100 member AstraZeneca is up by 20% in 2018
Roland Head asks whether FTSE 100 (INDEXFTSE:UKX) dividend stock AstraZeneca plc (LON:AZN) deserves a buy rating. Read More »
-
Don’t panic! How I think you can Brexit-proof your shares portfolio with these FTSE 100 dividend stocks
If you're worried about Brexit, then I think shopping for these FTSE 100 (INDEXFTSE: UKX) dividend stocks should be at the top of your... Read More »
